Yahoo Web Search

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 5 days ago

      GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024